{"url":"https://lda.senate.gov/api/v1/filings/0780de4e-6d8e-40f4-9f17-eea2e9da7c0e/","filing_uuid":"0780de4e-6d8e-40f4-9f17-eea2e9da7c0e","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2016,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/0780de4e-6d8e-40f4-9f17-eea2e9da7c0e/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"TJ Hartten","dt_posted":"2016-07-12T14:09:09.073000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"701 8th Street, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":41454,"url":"https://lda.senate.gov/api/v1/registrants/41454/","house_registrant_id":30771,"name":"WILLIAMS AND JENSEN, PLLC","description":"Lobbying Law Firm","address_1":"1201 Pennsylvania Avenue, NW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ISABELLA QUINN","contact_telephone":"+1 202-659-8201","dt_updated":"2026-07-30T10:41:36.640087-04:00"},"client":{"id":151200,"url":"https://lda.senate.gov/api/v1/clients/151200/","client_id":924,"name":"ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP)","general_description":null,"client_government_entity":false,"client_self_select":null,"state":"DE","state_display":"Delaware","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"21st Century Cures Initiative (House Energy and Commerce Committee) and Innovations for Healthier Americans (Senate Health, Education, Labor and Pensions Committee); possible drug provisions in FY 2017 appropriations bills; Drug safety and drug counterfeiting; Drug importation; 340B Program; Authorized generics; Drug company patent settlements; Senate Finance Committee Chronic Disease Initiative; Implementation of Precision Medicine Initiative; White House Cancer Moonshot; Legislation affecting the ESRD program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":18077,"prefix":null,"prefix_display":null,"first_name":"GEORGE","nickname":null,"middle_name":null,"last_name":"OLSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":37173,"prefix":null,"prefix_display":null,"first_name":"KARINA","nickname":null,"middle_name":null,"last_name":"LYNCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14682,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"HIRSCHMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":48784,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"B","last_name":"HOEKSTRA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65303,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":"BOOK","last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":43395,"prefix":"ms","prefix_display":"MS.","first_name":"MELINDA","nickname":null,"middle_name":"M","last_name":"MAXFIELD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61426,"prefix":null,"prefix_display":null,"first_name":"CHERYL","nickname":null,"middle_name":"LYNN","last_name":"JAEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":10,"name":"Vice President of the U.S."}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Tax issues affecting the pharmaceutical industry, tax reform issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":18077,"prefix":null,"prefix_display":null,"first_name":"GEORGE","nickname":null,"middle_name":null,"last_name":"OLSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":10,"name":"Vice President of the U.S."}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare prescription drug benefit; Drug rebates for Medicare Part D; Part D benefit structure; Payment policies for Medicare Part B Prescription drugs; Independent Payment Advisory Board (IPAB).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":18077,"prefix":null,"prefix_display":null,"first_name":"GEORGE","nickname":null,"middle_name":null,"last_name":"OLSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":37173,"prefix":null,"prefix_display":null,"first_name":"KARINA","nickname":null,"middle_name":null,"last_name":"LYNCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65303,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":"BOOK","last_name":"MULLEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":15838,"prefix":"mr","prefix_display":"MR.","first_name":"JACK","nickname":null,"middle_name":"STEVEN","last_name":"HART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":14682,"prefix":null,"prefix_display":null,"first_name":"SUSAN","nickname":null,"middle_name":null,"last_name":"HIRSCHMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":48784,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"B","last_name":"HOEKSTRA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61426,"prefix":null,"prefix_display":null,"first_name":"CHERYL","nickname":null,"middle_name":"LYNN","last_name":"JAEGER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":10,"name":"Vice President of the U.S."}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}